Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| FDA approves new combination for hypertension - TheHeart.Org |
 |
 |
|
TheHeart.Org Patients with renal impairment should be monitored for worsening renal function. Hypokalemia is a dose-dependent adverse reaction that may develop with chlorthalidone; Edarbyclor attenuates chlorthalidone-associated hypokalemia. ... FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the |
